Home » Natural Remedies Dog Cat » Reishi mushroom cats dogs What integration?

Reishi mushroom cats dogs What integration?

  • Elicats 
Reishi mushroom cats

Reishi mushroom cats dogs. Micotherapy, the use of medicinal mushrooms in the prevention and cure of many pathologies, the therapeutic effects of Reishi, mushroom of immortality, the first mushroom with pharmacological properties studied for over three thousand years and not coincidentally reserved exclusively to Chinese and Japanese reigners. The artificial cultivation began in 1970.

Reishi mushroom cats

REISHI – Ling Zhi THE MUSHROOM THAT MAKES YOU IMMORTAL

ADAPTOGENIC ACTION – IMMUNOMODULATORY – IMMUNOSTIMULATING

Reishi highly titrated in the content of beta-glucans Reishi Ganoderma – beta-glucans

It is important to recognize the best and effective product

AN OPTIMAL METHOD OF PRODUCTION GUARANTEES

THE THERAPEUTIC EFFICACY OF REISHI MUSHROOM

  • Selection of the spores
  • Land where it is grown
  • Harvest time and method of preparation
  • Packaging

Reishi Ganoderma – beta-glucans are what counts

ALWAYS VERIFY

PACKAGE – LABEL – ANALYSIS

Essential informations in order to obtain therapeutic results

  • Which part of the mushroom is contained (mycelium – extract – spores – whole mushroom)
  • Quantity per capsule
  • Titration: percentage in POLYSACCHARIDES percentage in BETA-GLUCANS
  • Organic Certification
  • GMP – Good manufacturing practice –
  • Presence of additives or other excipients

Reishi Ganoderma

beta-glucans are what counts

Medicinal mushrooms possess very powerful therapeutic effects thanks to the content of substances with pharmacological activity such as beta-glucans, composed of: proteins, essential amino acids, carbohydrates, dietary fibers, phosphorus, potassium, calcium, vitamin C, B1, B2, B12, beta-carotene.

 Beta-glucans

Stimulate the immune system: natural immunity and specific immunity, when you need to defend yourself from external aggressions

They stimulate the bone marrow to produce stem cells, direct cytotoxic action in vitro, when in contact with tumor cells

They interact with the immune system and are able to modify the biological response of the host: they are defined (BRM = Biological Response Modifiers)

 Stimulate macrophages, the neutrophils, Natural Killer cells (NK) to attack and kill sensitive tumor cells

Reishi – Ling Zhi

What it contains: Mineral salts: Iron, Zinc, Copper, Manganese, Magnesium, Potassium, Calcium, Germanium, B vitamins (folic acid or vitamin B9) 17 amino acids, Adenosine, Triterpenes.Triterpeni.

INDICATIONS

– HIGH BLOOD PRESSURE (HBP): it inhibits platelet aggregation and lowers arterial blood pressure, arrhythmias, similar effect to Ace-inhibitor

– REDUCE CHOLESTEROL: prevent the endogenous synthesis of cholesterol, reducing enteric absorption (intestine)

– ALLERGIES  Histamine-like activity, substances with cortisonic and antihistamine actions – eczema, asthma, food intolerances

– GLUCOSE METABOLISM: polysaccharides (Ganodermans) possess hypoglycemic effects = INCREASE INSULIN LEVELS/STIMULATION OF LIVER GLUCOSE METABOLISM

– POWERFUL ANTI-INFLAMMATORY: in vitro studies have demonstrated that 50 mg of Reishi have the same effect as 5 mg of cortisone, benefits in chronic inflammatory diseases such as rheumatoid arthritis

– HEPATOPROTECTIVE: it reduces transaminases and bilirubin, protects the liver during chemotherapy, hepatitis A, B, C – hepatic steatosis

WARNINGS AND PRECAUTIONS

Caution if you are taking anticoagulants, hypoglycemic agents, do not use in transplant patients or in treatment with immunosuppressive agents

Reishi cats dogs (Ganoderma) Beta-glucans are what counts

 

Salva

Reishi mushroom cats

Bibliografia

Brown GD, Gordon S. (2001) Immune recognition: a new receptor for glucans. Ross GD, Vetvicka V, Yan J, Xia Y, Vetvickova J. (1999) Therapeutic intervention with complement glucan in cancer. Immunopharmacology Yan J, Vetvicka V, Xia Y, Coxon A, Carrol MC, Mayadas TN, Ross GD (1999) ‚-glucan, a specific biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18). J.Immunol